cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2020-35-1-167-176cardiotomsk-928Research ArticleОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ И ОБЩЕСТВЕННОЕ ЗДОРОВЬЕHEALTHCARE AND PUBLIC HEALTHАбдоминальное ожирение и другие компоненты метаболического синдрома среди молодого населения г. НовосибирскаAbdominal obesity and other components of metabolic syndrome among the young population of Novosibirskhttps://orcid.org/0000-0002-4936-8362РагиноЮ. И.RaginoYu. I.

Dr. Sci. (Med.), Corresponding Member of the Russian Academy of Sciences, Acting Head

175/1, B. Bogatkova str., Novosibirsk, 630089, Russian Federation

ragino@mail.ruhttps://orcid.org/0000-0001-5893-7726ОблауховаВ. И.OblaukhovaV. I.

175/1, B. Bogatkova str., Novosibirsk, 630089, Russian Federation

napryushkina34@gmail.comhttps://orcid.org/0000-0002-2470-2133ДенисоваД. В.DenisovaD. V.

Dr. Sci. (Med.), Leading Research Scientist, Laboratory of Preventive Medicine

175/1, B. Bogatkova str., Novosibirsk, 630089, Russian Federation

denisovadiana@gmail.comhttps://orcid.org/0000-0001-5368-1899КовальковаН. А.KovalkovaN. A.

Cand. Sci. (Med.), Head of Research and Innovation Department

175/1, B. Bogatkova str., Novosibirsk, 630089, Russian Federation

terap2000@yandex.ruНаучно-исследовательский институт терапии и профилактической медицины – филиал Федерального государственного бюджетного научного учреждения «Федеральный исследовательский центр «Институт цитологии и генетики Сибирского отделения Российской академии наук»РоссияResearch Institute of Internal and Preventive Medicine, Russian Academy of SciencesRussian Federation202012042020351167176Copyright © Рагино Ю.И., Облаухова В.И., Денисова Д.В., Ковалькова Н.А., 20202020Рагино Ю.И., Облаухова В.И., Денисова Д.В., Ковалькова Н.А.Ragino Y.I., Oblaukhova V.I., Denisova D.V., Kovalkova N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/928абдоминальное ожирениеметаболический синдромпопуляциямолодое населениеabdominal obesitymetabolic syndromepopulationyoung adultsReferencesPatel K.K., Taksler G.B., Hu B., Rothberg M.B. Prevalence of elevated cardiovascular risks in young adults: A cross-sectional analysis of national health and nutrition examination surveys. Annals of Internal Medicine. 2017;166(12):876–882. DOI: 10.7326/m16-2052.Patel K.K., Taksler G.B., Hu B., Rothberg M.B. Prevalence of elevated cardiovascular risks in young adults: A cross-sectional analysis of national health and nutrition examination surveys. Annals of Internal Medicine. 2017;166(12):876–882. DOI: 10.7326/m16-2052.Рекомендации экспертов Всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома. Второй пересмотр. Практическая медицина. 2010;5(44):81–101.Recommendations of experts of Russian Scientific Society of Cardiologists on diagnosis and treatment of metabolic syndrome (2nd revision). Prakticheskaya meditsina. 2010;5(44):81–101 (In Russ.).Singh M., Benencia F. Inflammatory processes in obesity: focus on endothelial dysfunction and the role of adipokines as inflammatory mediators. Int. Rev. Immunol. 2019;38(4):157–171. DOI: 10.1080/08830185.2019.1638921.Singh M., Benencia F. Inflammatory processes in obesity: focus on endothelial dysfunction and the role of adipokines as inflammatory mediators. Int. Rev. Immunol. 2019;38(4):157–171. DOI: 10.1080/08830185.2019.1638921.Мониторирование сердечно-сосудистой заболеваемости, смертности и их факторов риска в разных регионах мира (проект ВОЗ MONICA), в 2 т. Под ред. акад. Никитина Ю.П. Новосибирск: акад. изд-во ГЕО; 2016:699.Monitoring of cardiovascular morbidity, mortality and their risk factors in different regions of the world (WHO MONICA project) in two volumes; edit. by Acad. Nikitin Yu.P. Novosibirsk: Acad. Publishing House GEO; 2016:699 (In Russ.).Ryden L., Standl E., Bartnik M., den Berghe G.V., Betteridge J., de Boer M. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J. Suppl. 2007;9(C1):C3–C74. DOI: 10.1093/eurheartj/ehl261.Ryden L., Standl E., Bartnik M., den Berghe G.V., Betteridge J., de Boer M. et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text. The Task Force on Diabetes and Cardiovascular Diseasesof the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur. Heart J. Suppl. 2007;9(C1):C3–C74. DOI:10.1093/eurheartj/ehl261.Pasternak R. National Cholesterol Education Program (NCEP) Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults: Adult Treatment Panel III (ATP III). ACC Cur. J. Rev. 2002;11(4):37–45. DOI: 10.1016/s1062-1458(02)00670-0.Pasternak R. National Cholesterol Education Program (NCEP) Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults: Adult Treatment Panel III (ATP III). ACC Cur. J. Rev.Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med. 2006;23(5):469–480. DOI: 10.1111/j.1464-5491.2006.01858.x.2002;11(4):37–45. DOI: 10.1016/s1062-1458(02)00670-0.Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P., Cleeman J., Donato K. et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study ofAlberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med. 2006;23(5):469–480. DOI: 10.1111/j.1464-5491.2006.01858.x.Obesity. Circulation. 2009;120(16):1640–1645. DOI: 10.1161/circulationaha.109.192644.Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P., Cleeman J., Donato K. et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. DOI: 10.1161/circulationaha.109.192644.Инвалидность и социальное положение инвалидов в России; под ред. Т.М. Малевой. М.: Дело; 2017:256.Disability and social status of disabled people in Russia; еdit. T.M. Malyova. Moscow: Delo; 2017:256 (In Russ.).Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;252:207–274. DOI: 10.1016/j.atherosclerosis.2016.05.037.Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;252:207–274. DOI: 10.1016/j.atherosclerosis.2016.05.037.Муромцева Г.А., Концевая А.В., Константинов В.В., Артамонова Г.В., Гатагонова Т.М., Дупляков Д.В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014;13(6):4–11. DOI: 10.15829/1728-8800-2014-6-4-11.Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V., Artamonova G.V., Gatagonova T.M., Duplyakov D.V. et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012–2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4–11. DOI: 10.15829/1728-8800-2014-6-4-11 (In Russ.).Gruzdeva O.V., Akbasheva O.E., Dyleva Y.A., Antonova L.V., Matveeva V.G., Uchasova E.G. et al. Adipokine and cytokine profiles of epicardial and subcutaneous adipose tissue in patients with coronary heart disease. Bull. Exp. Biol. Med. 2017;163(5):608–611. DOI: 10.1007/s10517-017-3860-5.Gruzdeva O.V., Akbasheva O.E., Dyleva Y.A., Antonova L.V., Matveeva V.G., Uchasova E.G. et al. Adipokine and сytokine рrofiles of еpicardial and subcutaneous adipose tissue in patients with coronary heart disease. Bull. Exp. Biol. Med. 2017;163(5):608–611 . DOI: 10.1007/s10517-017-3860-5.Учасова Е.Г., Груздева О.В., Дылева Ю.А., Белик Е.В., Барбараш О.Л. Роль иммунных клеток в развитии дисфункции жировой ткани при сердечно-сосудистых заболеваниях. Российский кардиологический журнал. 2019;24(4):92–98. DOI: 10.15829/1560-4071-2019-4-92-98.Uchasova E.G., Gruzdeva O.V., Dyleva Yu.A., Belik E.V., Barbarash O.L. The role of immune cells in the development of adipose tissue dysfunction in cardiovascular diseases. Russian Journal of Cardiology. 2019;(4):92–98 (In Russ.). DOI: 10.15829/1560-4071-2019-4-92-98.Alexopoulos N., Katritsis D., Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis. 2014;233(1):104–112. DOI: 10.1016/j.atherosclerosis.2013.12.023.Alexopoulos N., Katritsis D., Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis. 2014;233(1):104–112. DOI: 10.1016/j.atherosclerosis.2013.12.023.Баланова Ю.А., Шальнова С.А., Имаева А.Э., Капустина А.В., Муромцева Г.А., Евстифеева С.Е. и др. Распространенность артериальной гипертонии, охват лечением и его эффективность в Российской Федерации (данные наблюдательного исследования ЭССЕ-РФ-2). Рациональная Фармакотерапия в Кардиологии. 2019;15(4):450–466. DOI: 10.20996/1819-6446-2019-15-4-450-466.Balanova Y.A., Shalnova S.A., Imaeva A.E., Kapustina A.V., Muromtseva G.A., Evstifeeva S.E. et al. Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSE-RF-2 Study). Rational Pharmacotherapy in Cardiology. 2019;15(4):450–466 (In Russ.). DOI: 10.20996/1819-6446-2019-15-4-450-466.Potočnjak I., Bodrožić-Džakić T., Šmit I., Trbušić M., Milošević M., Degoricija V. Gender-associated differences in acute heart failure patients presenting to emergency department. Acta Clinica Croatica. 2015;54(3):257–265.Potočnjak I., Bodrožić-Džakić T., Šmit I., Trbušić M., Milošević M., Degoricija V. Gender-associated differences in acute heart failure patients presenting to emergency department. Acta Clinica Croatica. 2015;54(3):257–265.Kes V.B., Jurašić M.J., Zavoreo I., Lisak M., Jelec V., Matovina L.Z. Age and gender differences in acute stroke hospital patients. Acta Clinica Croatica. 2016;55(1):69–78.Kes V.B., Jurašić M.J., Zavoreo I., Lisak M., Jelec V., Matovina L.Z. Age and gender differences in acute stroke hospital patients. Acta Clinica Croatica. 2016;55(1):69–78.Оганов Р.Г., Масленникова Г.Я. Гендерные различия кардиоваскулярной патологии. Кардиоваскулярная терапия и профилактика. 2012;11(4):101–104.Oganov R.G., Maslennikova G.Ya. Gender differences in cardiovascular pathology. Cardiovascular Therapy and Prevention. 2012;11(4):101–104 (In Russ.).Pechère-Bertschi A., Burnier M. Female sex hormones, salt, and blood pressure regulation. Am. J. Hypertens. 2004;17(10):994–1001. DOI: 10.1016/j.amjhyper.2004.08.009.Pechère-Bertschi A., Burnier M. Female sex hormones, salt, and blood pressure regulation. Am. J. Hypertens. 2004;17(10):994–1001. DOI: 10.1016/j.amjhyper.2004.08.009.Кунцевич А.К., Мустафина С.В., Веревкин Е.Г., Денисова Д.В., Малютина С.К., Батлук Т.И. и др. Оценка связи фактического питания с фактором риска атеросклероза – абдоминальным ожирением у женщин г. Новосибирска. Атеросклероз. 2017;13(4):25–31. DOI: 10.15372/ATER20170404.Kuntsevich A.K., Mustafina S.V., Verevkin E.G., Denisova D.V., Malyutina S.K., Batluk T.I. et al. Association of dietary intake with a risk factor of atherosclerosis – abdominal obesity among women of Novosibirsk. Atherosclerosis. 2017;13(4):25–31 (In Russ.). DOI: 10.15372/ATER20170404.Di Pilla M., Bruno R.M., Taddei S., Virdis A. Gender differences in the relationships between psychosocial factors and hypertension. Maturitas. 2016;93:58–64. DOI: 10.1016/j.maturitas.2016.06.003.Di Pilla M., Bruno R.M., Taddei S., Virdis A. Gender differences in the relationships between psychosocial factors and hypertension. Maturitas. 2016;93:58–64. DOI: 10.1016/j.maturitas.2016.06.003.Баланова Ю.А., Шальнова С.А., Деев А.Д., Имаева А.Э., Концевая А.В., Муромцева Г.А. и др. Ожирение в российской популяции – распространенность и ассоциации с факторами риска хронических неинфекционных заболеваний. Российский кардиологический журнал. 2018;(6):123–130. DOI: 10.15829/1560-4071-2018-6-123-130.Balanova Y.A., Shalnova S.A., Deev A.D., Imaeva A.E., Kontsevaya A.V., Muromtseva G.A. et al. Obesity in Russian population – prevalence and association with the non-communicable diseases risk factors. Russian Journal of Cardiology. 2018;(6):123–130 (In Russ.). DOI: 10.15829/1560-4071-2018-6-123-130.Gierach M., Gierach J., Ewertowska M., Arndt A., Junik R. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinology. 2014:514589. DOI: 10.1155/2014/514589.Gierach M., Gierach J., Ewertowska M., Arndt A., Junik R. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinology. 2014:514589. DOI: 10.1155/2014/514589.Mattsson N., Rönnemaa T., Juonala M., Viikari J., Raitakari O. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J. Int. Med. 2007;261(2):159–169. DOI: 10.1111/j.1365 2796.2006.01752.x.Mattsson N., Rönnemaa T., Juonala M., Viikari J., Raitakari O. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J. Int. Med. 2007;261(2):159–169. DOI: 10.1111/j.1365 2796.2006.01752.x.Vernay M., Salanave B., de Peretti C., Druet C., Malon A., Deschamps V. et al. Metabolic syndrome and socioeconomic status in France: The French Nutrition and Health Survey (ENNS, 2006–2007). Int. J. Public. Health. 2013;58(6):855–864. DOI: 10.1007/s00038-013-0501-2.Vernay M., Salanave B., de Peretti C., Druet C., Malon A., Deschamps V. et al. Metabolic syndrome and socioeconomic status in France: The French Nutrition and Health Survey (ENNS, 2006–2007). Int. J. Public. Health. 2013;58(6):855–864. DOI: 10.1007/s00038-013-0501-2.Zuo H., Shi Z., Hu X., Wu M., Guo Z., Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 2009;58(8):1102–1108. DOI: 10.1016/j.metabol.2009.04.008.Zuo H., Shi Z., Hu X., Wu M., Guo Z., Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 2009;58(8):1102–1108. DOI: 10.1016/j.metabol.2009.04.008.

The authors declare that there are no conflicts of interest present.